Literature DB >> 19406972

Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.

Brian Siva1, Carmel M Hawley, Stephen P McDonald, Fiona G Brown, Johan B Rosman, Kathryn J Wiggins, Kym M Bannister, David W Johnson.   

Abstract

BACKGROUND AND OBJECTIVES: Pseudomonas peritonitis is a serious complication of peritoneal dialysis. To date, there as been no comprehensive, multicenter study of this condition. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The predictors, treatment, and clinical outcomes of Pseudomonas peritonitis were examined by binary logistic regression and multilevel, multivariate Poisson regression in all Australian PD patients in 66 centers between 2003 and 2006.
RESULTS: A total of 191 episodes of Pseudomonas peritonitis (5.3% of all peritonitis episodes) occurred in 171 individuals. Its occurrence was independently predicted by Maori/Pacific Islander race, Aboriginal/Torres Strait Islander race, and absence of baseline peritoneal equilibration test data. Compared with other organisms, Pseudomonas peritonitis was associated with greater frequencies of hospitalization (96 versus 79%; P = 0.006), catheter removal (44 versus 20%; P < 0.001), and permanent hemodialysis transfer (35 versus 17%; P < 0.001) but comparable death rates (3 versus 2%; P = 0.4). Initial empiric antibiotic choice did not influence outcomes, but subsequent use of dual anti-pseudomonal therapy was associated with a lower risk for permanent hemodialysis transfer (10 versus 38%, respectively; P = 0.03). Catheter removal was associated with a lower risk for death than treatment with antibiotics alone (0 versus 6%; P < 0.05).
CONCLUSIONS: Pseudomonas peritonitis is associated with high rates of catheter removal and permanent hemodialysis transfer. Prompt catheter removal and use of two anti-pseudomonal antibiotics are associated with better outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406972      PMCID: PMC2676190          DOI: 10.2215/CJN.00010109

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  10 in total

1.  Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.

Authors:  C C Szeto; K M Chow; C B Leung; T Y Wong; A K Wu; A Y Wang; S F Lui; P K Li
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

2.  End-stage renal disease in aboriginals in New South Wales: a very different picture to the Northern Territory.

Authors:  A Cass; A G Gillin; J S Horvath
Journal:  Med J Aust       Date:  1999-10-18       Impact factor: 7.738

3.  Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study.

Authors:  P H Juergensen; F O Finkelstein; R Brennan; S Santacroce; M J Ahern
Journal:  Am J Kidney Dis       Date:  1988-05       Impact factor: 8.860

Review 4.  Peritoneal dialysis-related infections recommendations: 2005 update.

Authors:  Beth Piraino; George R Bailie; Judith Bernardini; Elisabeth Boeschoten; Amit Gupta; Clifford Holmes; Ed J Kuijper; Philip Kam-Tao Li; Wai-Choong Lye; Salim Mujais; David L Paterson; Miguel Perez Fontan; Alfonso Ramos; Franz Schaefer; Linda Uttley
Journal:  Perit Dial Int       Date:  2005 Mar-Apr       Impact factor: 1.756

5.  Microbiology and outcomes of peritonitis in North America.

Authors:  S Mujais
Journal:  Kidney Int Suppl       Date:  2006-11       Impact factor: 10.545

Review 6.  Biofilms in peritoneal dialysis.

Authors:  M K Dasgupta; M Larabie
Journal:  Perit Dial Int       Date:  2001       Impact factor: 1.756

7.  Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA.

Authors:  Wai H Lim; David W Johnson; Stephen P McDonald
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

8.  End-stage renal disease in indigenous Australians: a disease of disadvantage.

Authors:  Alan Cass; Joan Cunningham; Paul Snelling; Zhiqiang Wang; Wendy Hoy
Journal:  Ethn Dis       Date:  2002       Impact factor: 1.847

9.  Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections.

Authors:  J Bernardini; B Piraino; M Sorkin
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

10.  Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study.

Authors:  M Bunke; M E Brier; T A Golper
Journal:  Am J Kidney Dis       Date:  1995-05       Impact factor: 8.860

  10 in total
  33 in total

1.  Risk factors and outcome of contamination in patients on peritoneal dialysis--a single-center experience of 15 years.

Authors:  Desmond Y H Yap; Wai Ling Chu; Flora Ng; Terence Pok Siu Yip; Sing Leung Lui; Wai Kei Lo
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

2.  Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.

Authors:  Manish M Sood; Paul Komenda; Amy R Sood; Martina Reslerova; Mauro Verrelli; Chris Sathianathan; Loretta Eng; Amanda Eng; Claudio Rigatto
Journal:  CMAJ       Date:  2010-07-26       Impact factor: 8.262

3.  Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.

Authors:  Luiz Gustavo Oliveira; Juliana Luengo; Jacqueline C T Caramori; Augusto C Montelli; Maria de Lourdes R S Cunha; Pasqual Barretti
Journal:  Int Urol Nephrol       Date:  2012-10       Impact factor: 2.370

4.  Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis.

Authors:  David W Johnson; Philip Clayton; Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Stephen McDonald; Neil Boudville; Kathryn J Wiggins; Kym Bannister; Fiona Brown
Journal:  Perit Dial Int       Date:  2012-02-01       Impact factor: 1.756

Review 5.  Peritoneal Dialysis-Associated Peritonitis.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-08       Impact factor: 8.237

6.  The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.

Authors:  Wen Tang; Yeoungjee Cho; Carmel M Hawley; Sunil V Badve; David W Johnson
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

7.  Pseudomonas luteola peritonitis with favorable outcome in continuous peritoneal dialysis.

Authors:  Darlene Gabaldon; Brenda Wiggins; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2013-07-17       Impact factor: 2.370

8.  Is female sex really a risk factor for infectious death in peritoneal dialysis?

Authors:  David W Johnson; Yeoungjee Cho; Rajnish Mehrotra
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

Review 9.  Peritoneal dialysis-related infections recommendations: 2010 update. What is new?

Authors:  Olga Nikitidou; Vassilios Liakopoulos; Triantafillia Kiparissi; Maria Divani; Konstantinos Leivaditis; Nicholas Dombros
Journal:  Int Urol Nephrol       Date:  2011-07-09       Impact factor: 2.370

10.  Changes in serum albumin concentrations during transition to dialysis and subsequent risk of peritonitis after peritoneal dialysis initiation: a retrospective cohort study.

Authors:  Kajohnsak Noppakun; Thanit Kasemset; Uraiwan Wongsawad; Chidchanok Ruengorn; Kednapa Thavorn; Manish M Sood; Surapon Nochaiwong
Journal:  J Nephrol       Date:  2020-03-04       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.